Pharmacokinetic Comparison of a Unit Dose Dry Powder Inhaler with a Multidose Dry Powder Inhaler for Delivery of Fluticasone Furoate

Rashmi Mehta; Alison Moore; Kylie Riddell; Shashidhar Joshi; Robert Chan

doi:10.1089/jamp.2016.1322

Pharmacokinetic Comparison of a Unit Dose Dry Powder Inhaler with a Multidose Dry Powder Inhaler for Delivery of Fluticasone Furoate

Journal of Aerosol Medicine and Pulmonary Drug Delivery ◽

10.1089/jamp.2016.1322 ◽

2017 ◽

Vol 30 (5) ◽

pp. 332-338

Author(s):

Rashmi Mehta ◽

Alison Moore ◽

Kylie Riddell ◽

Shashidhar Joshi ◽

Robert Chan

Keyword(s):

Dry Powder Inhaler ◽

Dry Powder ◽

Fluticasone Furoate ◽

Unit Dose

Download Full-text

Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD

International Journal of Chronic Obstructive Pulmonary Disease ◽

10.2147/copd.s32604 ◽

2014 ◽

pp. 249

Author(s):

Gaetano Caramori ◽

Ian Adcock ◽

Kian Fan Chung

Keyword(s):

Combination Therapy ◽

Dry Powder Inhaler ◽

Potential Treatment ◽

Dry Powder ◽

Fluticasone Furoate

Download Full-text

Pharmacokinetics of Salbutamol Delivered from the Unit Dose Dry Powder Inhaler: Comparison with the Metered Dose Inhaler and Diskus Dry Powder Inhaler

Journal of Aerosol Medicine and Pulmonary Drug Delivery ◽

10.1089/jamp.2015.1277 ◽

2017 ◽

Vol 30 (3) ◽

pp. 164-172 ◽

Cited By ~ 2

Author(s):

Alison Moore ◽

Kylie Riddell ◽

Shashidhar Joshi ◽

Robert Chan ◽

Rashmi Mehta

Keyword(s):

Dry Powder Inhaler ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Dry Powder ◽

Metered Dose ◽

Unit Dose

Download Full-text

In-vitro product performance of fluticasone furoate (FF)/umeclidinium (UMEC)/vilanterol (VI) delivered from a dry powder inhaler (DPI) using the Electronic Lung (EL) to replicate patient inhalation profiles

10.1183/13993003.congress-2019.pa4230 ◽

2019 ◽

Author(s):

David Prime ◽

Melanie Hamilton ◽

Edward Taylor

Keyword(s):

Dry Powder Inhaler ◽

Product Performance ◽

Dry Powder ◽

Fluticasone Furoate

Download Full-text

Fluticasone furoate/vilanterol dry-powder inhaler: a guide to its use in chronic obstructive pulmonary disease

Drugs & Therapy Perspectives ◽

10.1007/s40267-015-0195-z ◽

2015 ◽

Vol 31 (4) ◽

pp. 112-117

Author(s):

Kate McKeage

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Dry Powder Inhaler ◽

Chronic Obstructive ◽

Dry Powder ◽

Fluticasone Furoate ◽

Obstructive Pulmonary Disease

Download Full-text

Fluticasone furoate/vilanterol dry-powder inhaler in asthma: a guide to its use in the EU

Drugs & Therapy Perspectives ◽

10.1007/s40267-017-0392-z ◽

2017 ◽

Vol 33 (4) ◽

pp. 153-159

Author(s):

Emma D. Deeks ◽

Katherine A. Lyseng-Williamson ◽

Yahiya Y. Syed

Keyword(s):

Dry Powder Inhaler ◽

Dry Powder ◽

Fluticasone Furoate ◽

The Eu

Download Full-text

In-vitro product performance of fluticasone furoate (FF)/umeclidinium (UMEC)/vilanterol (VI) delivered from a dry powder inhaler (DPI) using the Electronic Lung (EL) to replicate patient inhalation profiles

10.1055/s-0039-3403161 ◽

2020 ◽

Author(s):

D Prime ◽

M Hamilton ◽

E Taylor

Keyword(s):

Dry Powder Inhaler ◽

Product Performance ◽

Dry Powder ◽

Fluticasone Furoate

Download Full-text

Double-Blind, Double-Dummy, Multinational, Multicenter, Parallel-Group Design Clinical Trial of Clinical Non-Inferiority of Formoterol 12 μg/Unit Dose in a b.i.d. Regimen Administered via an HFA-Propellant-pMDI or a Dry Powder Inhaler in a 12-Week Treatment Period of Moderate to Severe Stable Persistent Asthma in Adult Patients

Respiration ◽

10.1159/000083689 ◽

2005 ◽

Vol 72 (1) ◽

pp. 20-27 ◽

Cited By ~ 8

Author(s):

D. Dusser ◽

E. Vicaut ◽

G. Lefrançois

Keyword(s):

Clinical Trial ◽

Treatment Period ◽

Dry Powder Inhaler ◽

Persistent Asthma ◽

Dry Powder ◽

Double Blind ◽

Group Design ◽

Parallel Group Design ◽

Parallel Group ◽

Unit Dose

Download Full-text

Fluticasone furoate/umeclidinium/vilanterol dry-powder inhaler in COPD: a profile of its use in the EU

Drugs & Therapy Perspectives ◽

10.1007/s40267-018-0513-3 ◽

2018 ◽

Vol 34 (6) ◽

pp. 241-247

Author(s):

Yahiya Y. Syed ◽

Katherine A. Lyseng-Williamson

Keyword(s):

Dry Powder Inhaler ◽

Dry Powder ◽

Fluticasone Furoate ◽

The Eu

Download Full-text

Ex-Vivo Product Performance Of Fluticasone Furoate/Vilanterol Delivered From A Novel Dry Powder Inhaler, Using The Electronic Lung To Replicate Asthma And COPD Patient Inhalation Profiles

10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2940 ◽

2012 ◽

Cited By ~ 1

Author(s):

Melanie Hamilton ◽

David Prime ◽

Richard Leggett

Keyword(s):

Ex Vivo ◽

Dry Powder Inhaler ◽

Product Performance ◽

Dry Powder ◽

Fluticasone Furoate

Download Full-text

CONSISTENCY OF DOSE DELIVERY OF FLUTICASONE FUROATE (FF)/UMECLIDINIUM (UMEC)/VILANTEROL (VI) ACROSS PATIENT RELEVANT INHALATION FLOW RATES FROM A DRY-POWDER INHALER (DPI)

CHEST Journal ◽

10.1016/j.chest.2019.08.1550 ◽

2019 ◽

Vol 156 (4) ◽

pp. A1786

Author(s):

David Prime ◽

Melanie Hamilton ◽

Oonagh Patmore

Keyword(s):

Dry Powder Inhaler ◽

Dose Delivery ◽

Dry Powder ◽

Fluticasone Furoate ◽

Flow Rates

Download Full-text